↓ Skip to main content

Denosumab combined with chemotherapy followed by anlotinib in the treatment of multiple metastases of malignant peripheral nerve sheath tumor: a case report and literature review

Overview of attention for article published in Frontiers in oncology, July 2024
Altmetric Badge

Mentioned by

twitter
1 X user
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Denosumab combined with chemotherapy followed by anlotinib in the treatment of multiple metastases of malignant peripheral nerve sheath tumor: a case report and literature review
Published in
Frontiers in oncology, July 2024
DOI 10.3389/fonc.2024.1399021
Authors

Qian Chen, Haocheng Cui, Kai Zheng, Ming Xu, Xiuchun Yu

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 July 2024.
All research outputs
#21,485,559
of 26,370,058 outputs
Outputs from Frontiers in oncology
#11,910
of 23,047 outputs
Outputs of similar age
#88,556
of 138,607 outputs
Outputs of similar age from Frontiers in oncology
#36
of 124 outputs
Altmetric has tracked 26,370,058 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 23,047 research outputs from this source. They receive a mean Attention Score of 3.2. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 138,607 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 124 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.